Drug therapy: Sulfasalazine.
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D001667:Binding, Competitive; D001692:Biological Transport / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004341:Drug Evaluation; D004347:Drug Interactions; D005260:Female; D005492:Folic Acid / Q000378:metabolism; D006801:Humans; D007408:Intestinal Absorption; D007422:Intestines / Q000382:microbiology; D007501:Iron / Q000378:metabolism; D010919:Placebos; D011247:Pregnancy; D011349:Proctitis / Q000188:drug therapy; D012008:Recurrence; D013427:Sulfapyridine / Q000097:blood; D012460:Sulfasalazine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D010919:Placebos; D012460:Sulfasalazine; D005492:Folic Acid; D007501:Iron; D013427:Sulfapyridine